Table II.
Incidence of arrhythmia and the change in ST-T in the IVIG and control groups pre- and post-treatment.
| IVIG group (n=32) | Control group (n=26) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||||||
| Time-point | Bradycardia | AVB | VT/VF | Atrial arrhythmia | Ventricular arrhythmia | BBB | ST-T change | Bradycardia | AVB | VT/VF | Atrial arrhythmia | Ventricular arrhythmia | BBB | ST-T change |
| Baseline n (%) | 17 (53.1) | 17 (53.1) | 8 (25.0) | 6 (18.8) | 10 (31.3) | 17 (53.1) | 25 (78.1) | 11 (42.3) | 8 (30.8) | 3 (11.5) | 2 (7.7) | 6 (23.1) | 6 (23.1) | 15 (57.7) |
| Post-treatment n (%) | 4 (12.5) | 3a (9.4) | 1a (3.1) | 1 (3.1) | 2 (6.3) | 6 (18.8) | 12 (37.5) | 3 (11.5) | 4 (15.4) | 3 (11.5) | 0 (0.0) | 3 (11.5) | 4 (15.4) | 7 (26.9) |
a
P<0.05 vs. baseline value.
AVB, atrioventricular block; VT, ventricular tachycardia; VF, ventricular fibrillation; BBB, bundle branch block; IVIG, intravenous immunoglobulin.